Affymax develops a drug fighting against anemia
Deloitte’s annual Silicon Valley Fast 50 identifies the fastest growing Silicon Valley companies measured by five years of revenue growth.
Affymax (NASDAQ: AFFY) was the fastest growing of all the companies in Deloitte’s scientific, medical equipment and biotech category. Last quarter the Palo Alto-based company had revenue of $21.6 million, compared with $10.5 million a year ago, but lost $26.2 million, compared with a loss of $12.7 million.
Affymax only product is Hematide, a drug treating anemia in chronic renal failure due to the progressive loss of kidney function.
Here are the other first 12 fastest scientific, medical equipment and biotech startups with their location and 5-year growth. We will publish 13 to 24 tomorrow.
Affymax, Palo Alto, 19605%
InSite Vision, Alameda, 17632%
SunPower, San Jose, 15380%
DepoMed, Menlo Park, 6578%
Accuray, Sunnyvale, 5083%
Nuvelo, San Carlos, 4476%
XenoPort, Santa Clara, 1727%
Dynavax Technologies, Berkeley, 1606%
Alpha Innotech, San Leandro, 1186%
BioMarin Pharmaceutical, Novato, 905%
Neurobiological Technologies, Emeryville, 793%
Conceptus, Mountain View, 737%
Jean-Baptiste Su
Mark Boslet
chiahwu